(Q44946348)

7 December 2017

Histidine-rich glycoprotein as an early biomarker of preeclampsia (English)

1 reference

7 December 2017

0 references

0 references

Marie Bolin

1

1 reference

7 December 2017

Peter Akerud

series ordinal

2

1 reference

7 December 2017

Agneta Hansson

series ordinal

3

1 reference

7 December 2017

Helena Akerud

series ordinal

4

1 reference

7 December 2017

20 January 2011

1 reference

Journal of Clinical Hypertension

7 December 2017

1 reference

7 December 2017

24

1 reference

7 December 2017

4

1 reference

7 December 2017

496-501

1 reference

Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia

7 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Preeclampsia: an endothelial cell disorder

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Hemostatic abnormalities in patients with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Fibrinogen concentration and factor VIII activity in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Increased high molecular weight fibrinogen in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Fibrinogen and fibrin structure and functions

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Prediction and prevention of preeclampsia and IUGR.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Angiogenic factors and preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Serum markers for predicting pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Histidine-rich glycoprotein as a negative acute phase reactant

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Interaction of histidine-rich glycoprotein with fibrinogen and fibrin

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.264

7 January 2021

Identifiers

DOI

10.1038/AJH.2010.264

1 reference

7 December 2017

1 reference